GSK OUTLOOK FY CORE OPERATING PROFIT GROWTH 7-9%
GSK OUTLOOK FY CORE OPERATING PROFIT GROWTH 7-9%
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
GSK Q2 SALES GBP 8,409 MILLION VS. IBES ESTIMATE GBP 8,239 MILLION || Q2 ADJUSTED OPERATING PROFIT GBP 2,800 MILLION VS. IBES ESTIMATE GBP 2
GSK Q2 SALES GBP 8,409 MILLION VS. IBES ESTIMATE GBP 8,239 MILLION || Q2 ADJUSTED OPERATING PROFIT GBP 2,800 MILLION VS. IBES ESTIMATE GBP 2,646 MILLION || Q2 ADJUSTED EPS GBP 0.505 VS. IBES ESTIMATE GBP 0.46 || OUTLOOK FY CORE OPERATING PROFIT GROWTH 7-9%
GSK GSK RESULTS: Q2, Q2 sales GBP 8.409B vs. EST GBP 8.239B, Q2 ADJ operating profit GBP 2.800B vs. EST GBP 2.646B, Q2 ADJ EPS GBP 0.505 vs.
GSK GSK RESULTS: Q2, Q2 sales GBP 8.409B vs. EST GBP 8.239B, Q2 ADJ operating profit GBP 2.800B vs. EST GBP 2.646B, Q2 ADJ EPS GBP 0.505 vs. EST GBP 0.46, Q2 dividend GBP 0.17, GSK Earnings Notes:, Outlook FY core operating profit growth 7-9%, Outlook FY turnover growth 3-5%, Outlook FY core EPS growth 7-9%, Now expect